The death of Greek singer Giorgos Mazonakis has drawn renewed international attention, with Politico examining the circumstances surrounding his death and questions over the regulation of Greece\u2019s rapidly expanding wellness and longevity industry.<\/h3>\n
The 54-year-old singer died earlier this month after suffering cardiac arrest while undergoing plasmapheresis, a medical procedure commonly used to treat autoimmune conditions. According to Politico, some wellness clinics also offer the procedure as a treatment promoted for detoxification and longevity.<\/p>\n The procedure took place at a private clinic in central Athens which, according to Health Minister Adonis Georgiadis, did not have a licence to perform the specific medical procedure.<\/p>\n The circumstances surrounding Mazonakis\u2019 death have prompted wider discussion in Greece about the oversight of private healthcare services. According to statements collected by judicial and police authorities, an 87-minute gap allegedly occurred between the singer losing consciousness and the emergency services being called.<\/p>\n Authorities also found that members of the clinic\u2019s staff had searched online for instructions on responding to an emergency requiring resuscitation, according to the report.<\/p>\n Questions over Greece\u2019s healthcare system<\/span><\/em><\/p>\n Politico quoted Elias Mossialos, Professor of Health Policy at the London School of Economics and director of LSE Health, who pointed to weaknesses in Greece\u2019s healthcare system.<\/p>\n Mossialos noted that Greece had taken a leading role in some areas, including the introduction of electronic prescribing in 2010-11, which he described as a significant development by European standards.<\/p>\n He argued, however, that subsequent digital development had not kept pace.<\/p>\n \u201cBut the system stopped there. Patient records did not evolve accordingly, and the digital infrastructure that could have formed the backbone of a modern healthcare system remained incomplete,\u201d Mossialos told Politico.<\/p>\n He also pointed to what he described as a lack of systematic monitoring of healthcare quality and long-term planning for the medical specialties and skills Greece will need as its population becomes smaller and older.<\/p>\n Debate over Medwatch<\/span><\/em><\/p>\n Politico also examined Medwatch, the Health Ministry\u2019s new oversight framework, which includes a QR-code system allowing users to verify whether relevant businesses hold the required licences.<\/p>\n Mossialos said the system addresses a limited question: whether a clinic has a licence and whether information in its advertising is accurate.<\/p>\n \u201cIt is reasonable to check these things, but they say nothing about the quality of care provided inside the clinic,\u201d he said, arguing that licensing represents a minimum requirement rather than a measure of healthcare quality.<\/p>\n Political debate over health oversight<\/span><\/em><\/p>\n The Mazonakis case has also triggered political criticism, with opposition parties and healthcare experts questioning how Greece regulates the sector, according to Politico.<\/p>\n The report refers to the abolition in 2019 of SEYYP, the specialised health inspectors\u2019 unit, after the New Democracy government took office. Oversight responsibilities subsequently moved among other bodies, including local medical associations and the National Transparency Authority.<\/p>\n Politico also cited a Greek police statement referring to a \u201csupervisory gap\u201d in healthcare services.<\/p>\n Georgiadis had previously said he would not oppose restoring SEYYP before, according to the report, revising that position several days later.<\/p>\n Georgiadis and the longevity sector<\/span><\/em><\/p>\n The Politico report also examines Georgiadis\u2019 previous activities and his support for expanding private healthcare and the longevity sector.<\/p>\n The report notes that the health minister has visited a longevity clinic in Attica and called for investment in Greece\u2019s healthcare sector, including efforts to attract high-income visitors from the Middle East.<\/p>\n It also refers to Georgiadis\u2019 earlier appearance on a television shopping channel, where he promoted products known as \u201cnanobionic vests\u201d. Georgiadis recently described the episode as a \u201cmistake of the past\u201d, saying the products were selected solely for commercial reasons.<\/p>\n New framework for longevity services<\/span><\/em><\/p>\n Following the public reaction to Mazonakis\u2019 death and the debate surrounding wellness services, Georgiadis announced the creation of a committee to establish a clear regulatory framework for longevity services, regenerative medicine and related medical procedures.<\/p>\n \u201cI will not ban longevity in Greece,\u201d he said in an interview with ERT, arguing that longevity represents a rapidly expanding international medical-services sector.<\/p>\n According to the minister, similar services are already developing in countries including Germany, the United Arab Emirates and Turkey.<\/p>\n The debate has consequently widened beyond the circumstances of Mazonakis\u2019 death to questions about how Greece regulates emerging private health and longevity services, and how authorities can distinguish between licensed medical care and services marketed primarily through the growing wellness industry.<\/p>\n \u00a0<\/p>\n![\"\"](\"https:\/\/greekcitytimes.com\/wp-content\/uploads\/2026\/09\/Screenshot-2026-09-27-at-6.40.30-pm.webp)
<\/source><\/picture><\/p>\n